1583-1584 Nyland Federal Assembly

[Seperallis]

National Medical Relief Act of 1583
Assembly Bill 1583.132
Drafted by: Special Committee for the Reform of Healthcare, Department of Health Submitted by: Rosario Manrique (NL), Milan Vuletaski (NL) Submit Date: 6 Dein, 1583 Hearing Date: Revision Date: Summary: This bill overhauls and modernizes Nyland's healthcare system by combining both the prescription and medical voucher subsidies into one program, expands the payouts of the federal Medical Voucher Program to meet increases in medical expenses, expands insurance coverage to those with pre-existing conditions, allows, the Medical Voucher Program to combat rising costs by negotiating prices, and installs the Medical and Prescription Prices Review Board as a means to control unreasonable medical costs. Section 1: Medical Voucher Program 1) The Medical Voucher Program (MVP) shall be automatically adjusted annually to match inflation per the Consumer Price Index (CPI) of all medical goods and services. 2) All medical goods and services so classified as such under the VAT program shall be exempt from VAT when purchased via the MVP. 3) The MVP shall be expanded on the following basis: 3.1) $5000 voucher per adult earning $50,000 adjusted gross income (AGI) or less per year, with a maximum of 2 such vouchers per household, to phase out on a linear basis until an AGI of $100,000 is reached, at which point the adult voucher shall be $0. 3.2) $2000 voucher per dependent person per family earning an AGI of $50,000 or less, up to a maximum of 4 such vouchers per household, to phase out on a linear basis until an AGI of $100,000 is reached, at which point the dependent voucher shall be $0. 4) Any taxpaying citizen so choosing so may opt-out of the federal Medical Voucher Program by participating in an equivalent state medical voucher program. 5) The MVP shall be used to pay for all qualified and necessary medical expenses as determined by a schedule set by the Medical and Prescription Prices Review Board, to include the purchase of private health insurance. 6) All private insurance companies accepting the use of the Medical Voucher Program must offer and accept coverage for persons with preexisting and detrimental medical conditions without discrimination or adjustment of premium prices. 7) The MVP shall be given the authority to negotiate prices with medical facilities, prescription drug manufacturers, private insurance providers, and other entities which may accept payment from the MVP. Section 2: Prescription Voucher Program 1) The separate Prescription Voucher Program (PVP) shall be eliminated, and its function and funding included in the Medical Voucher Program (MVP); the scope and function of the PVP shall be included hereafter in the scope and function of the MVP. Section 3: Medical and Prescription Prices Review Board 1) This act shall create the Medical and Prescription Prices Review Board, hereafter refered to as the MPPRB. 2) The MPPRB shall use and update lists of existing medical service diagnostic codes (including the International Statistical Classification of Diseases and Related Health Problems, ICD), catalog and monitor patents for medical procedures and prescription drugs, and set price controls - including initial drug prices and subsequent price increases - for medical procedures and prescription drugs both under patent and based upon its established catalog and the ICD. 3) Direct-to-consumer advertisement of patented medical procedures and patented prescription drugs shall be banned, and the MPPRB shall enforce this ban and regulate advertisement to the public for non-patented and generic pharmaceuticals and medical procedures. 4) The MPPRB shall have the authority to regulate pharmaseutical retail markup prices, with consideration to the advice of pharmaseutical retailers.